These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 26280277)

  • 1. Going viral: a review of replication-selective oncolytic adenoviruses.
    Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
    Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints.
    Jiang H; Gomez-Manzano C; Rivera-Molina Y; Lang FF; Conrad CA; Fueyo J
    Curr Opin Virol; 2015 Aug; 13():33-9. PubMed ID: 25863716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ReVOLT: radiation-enhanced viral oncolytic therapy.
    Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer gene therapy with oncolytic adenoviruses.
    Guse K; Hemminki A
    J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in oncolytic adenovirus therapies for cancer.
    Rosewell Shaw A; Suzuki M
    Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues and future directions of oncolytic adenoviruses.
    Yamamoto M; Curiel DT
    Mol Ther; 2010 Feb; 18(2):243-50. PubMed ID: 19935777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomical and physical barriers to tumor targeting with oncolytic adenoviruses in vivo.
    Strauss R; Lieber A
    Curr Opin Mol Ther; 2009 Oct; 11(5):513-22. PubMed ID: 19806499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in research on oncolytic adenoviruses in tumor therapy].
    Zhou XL; Tang WR
    Bing Du Xue Bao; 2014 May; 30(3):318-24. PubMed ID: 25118389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic adenoviruses - selective retargeting to tumor cells.
    Mathis JM; Stoff-Khalili MA; Curiel DT
    Oncogene; 2005 Nov; 24(52):7775-91. PubMed ID: 16299537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter four--Design of improved oncolytic adenoviruses.
    Alemany R
    Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells].
    Razumov IA; Sviatchenko VA; Protopopova EV; Kochneva GV; Kiselev NN; Gubanova NV; Shilov AG; Mordvinov VA; Netesov SV; Chumakov PM; Loktev VB
    Vestn Ross Akad Med Nauk; 2013; (12):4-8. PubMed ID: 24741936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viruses: adenoviruses.
    Niemann J; Kühnel F
    Virus Genes; 2017 Oct; 53(5):700-706. PubMed ID: 28702840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical development of oncolytic viruses in China.
    Liang M
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conditionally replicating adenovirus with strict selectivity in killing cells expressing epidermal growth factor receptor.
    Carette JE; Graat HC; Schagen FH; Mastenbroek DC; Rots MG; Haisma HJ; Groothuis GM; Schaap GR; Bras J; Kaspers GJ; Wuisman PI; Gerritsen WR; van Beusechem VW
    Virology; 2007 Apr; 361(1):56-67. PubMed ID: 17184803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From virotherapy to oncolytic immunotherapy: where are we now?
    Coffin RS
    Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.